Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Tenet Healthcare (NYSE:THC) from a buy rating to a strong-buy rating in a report released on Saturday morning,Wall Street Zen reports.

THC has been the topic of several other reports. Morgan Stanley upped their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Weiss Ratings upgraded shares of Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. TD Cowen boosted their target price on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Finally, Stephens restated an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Eighteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.45.

Tenet Healthcare Stock Down 2.9%

Shares of NYSE:THC opened at $267.27 on Friday. Tenet Healthcare has a 52 week low of $157.58 and a 52 week high of $283.05. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company’s fifty day moving average is $264.36 and its 200-day moving average is $219.07. The company has a market capitalization of $21.52 billion, a PE ratio of 10.31, a P/E/G ratio of 1.02 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the prior year, the firm earned $4.02 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts predict that Tenet Healthcare will post 21.04 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 10,878 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.90, for a total transaction of $2,653,144.20. Following the transaction, the executive vice president directly owned 18,413 shares in the company, valued at approximately $4,490,930.70. This represents a 37.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director J. Robert Kerrey sold 12,010 shares of the stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the sale, the director directly owned 4,794 shares in the company, valued at $1,264,273.68. This trade represents a 71.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 131,199 shares of company stock worth $35,065,587 over the last quarter. Corporate insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Manning & Napier Advisors LLC bought a new position in Tenet Healthcare in the 2nd quarter valued at $168,761,000. Arrowstreet Capital Limited Partnership increased its stake in shares of Tenet Healthcare by 57.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock valued at $126,757,000 after buying an additional 244,901 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Tenet Healthcare during the second quarter worth $106,342,000. Empowered Funds LLC lifted its stake in shares of Tenet Healthcare by 22.1% during the first quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock valued at $53,736,000 after acquiring an additional 51,549 shares during the period. Finally, Hsbc Holdings PLC lifted its stake in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after acquiring an additional 258,956 shares during the period. Institutional investors own 95.44% of the company’s stock.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet raised its 2026 outlook, strengthening the investment case by signaling better-than-expected earnings momentum. The guidance increase could lead to additional estimate revisions and supports the company’s growth narrative. Tenet Healthcare Lifts 2026 Outlook
• Positive Sentiment: Guggenheim raised its price target from $283 to $307 and maintained a Buy rating, implying additional potential upside based on the referenced share price. The target increase reflects greater confidence in Tenet’s earnings outlook. Guggenheim Raises Tenet Healthcare Price Target
• Positive Sentiment: Coverage highlighting Tenet as a long-term growth stock points to its improving fundamentals and potential for continued market outperformance. The guidance raise may further strengthen the bullish case. Why Tenet Healthcare Is a Top Growth Stock
• Neutral Sentiment: Wall Street Zen upgraded Tenet, adding to the generally favorable analyst tone, though the service’s rating change is less significant than the company’s guidance and earnings revisions. Tenet Healthcare Upgraded at Wall Street Zen
• Negative Sentiment: Zacks Research made a modest reduction to its fourth-quarter 2027 EPS estimate, from $5.13 to $5.12, and retains a Hold rating. The small cut is not material but tempers the bullish outlook. Zacks Research Cuts Tenet Healthcare EPS Estimate
• Negative Sentiment: Analysts are questioning whether Tenet’s rally has already priced in the improved outlook. With a forward P/E around 12.5 and shares near their annual high, further gains may require additional earnings upgrades. Tenet Healthcare Valuation Concerns

About Tenet Healthcare

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.